PKU HealthCare Corp Ltd Asset Resilience Ratio

Latest as of June 2026: 10.92%

PKU HealthCare Corp Ltd asset resilience ratio. PKU HealthCare Corp Ltd (000788) has an Asset Resilience Ratio of 10.92% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See PKU HealthCare Corp Ltd liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥210.04 Million
≈ $30.74 Million USD Cash + Short-term Investments

Total Assets

CN¥1.92 Billion
≈ $281.38 Million USD All company assets

Resilience Assessment

Moderate
Financial Resilience Level

Asset Resilience Ratio of PKU HealthCare Corp Ltd (2010–2014)

Asset resilience ratio of PKU HealthCare Corp Ltd from 2010 to 2014. This chart shows how PKU HealthCare Corp Ltd's Asset Resilience Ratio has changed over time. Read how much debt does PKU HealthCare Corp Ltd carry for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down PKU HealthCare Corp Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see PKU HealthCare Corp Ltd total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥210.04 Million 10.92%
Total Liquid Assets CN¥210.04 Million 10.92%

Asset Resilience Insights

  • Moderate Liquidity: PKU HealthCare Corp Ltd has 10.92% of assets in liquid form.
  • While adequate for normal operations, this level may limit flexibility during economic stress.
  • The company has significant short-term investments, indicating active treasury management.

PKU HealthCare Corp Ltd Industry Peers by Asset Resilience Ratio

Compare PKU HealthCare Corp Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
Drug Manufacturers - Specialty & Generic 0.16%
Sandoz Group AG
SW:SDZ
Drug Manufacturers - Specialty & Generic 7.89%
H Lundbeck A/S
CO:HLUN-B
Drug Manufacturers - Specialty & Generic -0.56%
Changchun High & New Technology Industries Group Inc
SHE:000661
Drug Manufacturers - Specialty & Generic 5.50%
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
Drug Manufacturers - Specialty & Generic 47.16%
Kangmei Pharmaceutical Co Ltd
SHG:600518
Drug Manufacturers - Specialty & Generic 0.00%
Viyash Scientific Limited
NSE:SEQUENT
Drug Manufacturers - Specialty & Generic 0.08%
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
Drug Manufacturers - Specialty & Generic 1.81%

PKU HealthCare Corp Ltd Asset Resilience Ratio by Year (2010–2014)

PKU HealthCare Corp Ltd asset resilience ratio by year from 2010 to 2014. The table below shows the annual Asset Resilience Ratio data for PKU HealthCare Corp Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2014-12-31 0.02% CN¥745.36K
≈ $109.07K
CN¥4.61 Billion
≈ $674.89 Million
+0.01pp
2013-12-31 0.01% CN¥408.53K
≈ $59.78K
CN¥4.23 Billion
≈ $618.84 Million
-0.04pp
2011-12-31 0.05% CN¥1.28 Million
≈ $187.12K
CN¥2.75 Billion
≈ $401.81 Million
+0.04pp
2010-12-31 0.00% CN¥37.81K
≈ $5.53K
CN¥1.98 Billion
≈ $289.61 Million
--
pp = percentage points

About PKU HealthCare Corp Ltd

SHE:000788 China Drug Manufacturers - Specialty & Generic
Market Cap
$463.09 Million
CN¥3.16 Billion CNY
Market Cap Rank
#12350 Global
#3561 in China
Share Price
CN¥5.31
Change (1 day)
+1.34%
52-Week Range
CN¥4.81 - CN¥7.52
All Time High
CN¥16.52
About

PKU HealthCare Corp.,Ltd. engages in the research, development, production, and sale of chemical pharmaceutical preparations, pharmaceutical distribution, and medical services in China. The company offers anti-infectives, analgesics, psychotropic drugs, digestive system drugs, and cardiovascular drugs; procurement and pharmacy outsourcing; and cancer screening, health management, and treatment se… Read more